View in EDS PDF Full Text

Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine.

Saved in:
Bibliographic Details
Title: Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine.
Authors: Martins RM; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil., Périssé ARS; National School of Public Health, Fiocruz, Rio de Janeiro, RJ, Brazil., Camacho LAB; National School of Public Health, Fiocruz, Rio de Janeiro, RJ, Brazil., Leal ML; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil., Maia MLS; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil., Homma A; Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil., Jessouroun E; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil. Electronic address: ellen@bio.fiocruz.br.
Source: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases [Braz J Infect Dis] 2021 Nov-Dec; Vol. 25 (6), pp. 101652. Date of Electronic Publication: 2021 Nov 16.
Publication Type: Clinical Trial, Phase I; Journal Article
Journal Info: Publisher: Elsevier Editora Country of Publication: Brazil NLM ID: 9812937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1678-4391 (Electronic) Linking ISSN: 14138670 NLM ISO Abbreviation: Braz J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34793713
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martins+RM%22">Martins RM</searchLink>; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil.<br /><searchLink fieldCode="AU" term="%22Périssé+ARS%22">Périssé ARS</searchLink>; National School of Public Health, Fiocruz, Rio de Janeiro, RJ, Brazil.<br /><searchLink fieldCode="AU" term="%22Camacho+LAB%22">Camacho LAB</searchLink>; National School of Public Health, Fiocruz, Rio de Janeiro, RJ, Brazil.<br /><searchLink fieldCode="AU" term="%22Leal+ML%22">Leal ML</searchLink>; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil.<br /><searchLink fieldCode="AU" term="%22Maia+MLS%22">Maia MLS</searchLink>; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil.<br /><searchLink fieldCode="AU" term="%22Homma+A%22">Homma A</searchLink>; Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil.<br /><searchLink fieldCode="AU" term="%22Jessouroun+E%22">Jessouroun E</searchLink>; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil. Electronic address: ellen@bio.fiocruz.br.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229812937%22">The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases</searchLink> [Braz J Infect Dis] 2021 Nov-Dec; Vol. 25 (6), pp. 101652. <i>Date of Electronic Publication: </i>2021 Nov 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Editora%22">Elsevier Editora </searchLink><i>Country of Publication: </i>Brazil <i>NLM ID: </i>9812937 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1678-4391 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214138670%22">14138670 </searchLink><i>NLM ISO Abbreviation: </i>Braz J Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34793713
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.bjid.2021.101652
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101652
    Titles:
      – TitleFull: Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martins RM
      – PersonEntity:
          Name:
            NameFull: Périssé ARS
      – PersonEntity:
          Name:
            NameFull: Camacho LAB
      – PersonEntity:
          Name:
            NameFull: Leal ML
      – PersonEntity:
          Name:
            NameFull: Maia MLS
      – PersonEntity:
          Name:
            NameFull: Homma A
      – PersonEntity:
          Name:
            NameFull: Jessouroun E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2021 Nov-Dec
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1678-4391
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
              Type: main
ResultId 1